News | January 07, 2008

Defibrillators, Cardiac Monitors Boost Cardiac Science Q407 Revenues

January 8, 2007 - Cardiac Science Corp. expects 2007 fourth quarter revenue to total approximately $50 million, representing growth of approximately 28 percent compared with the fourth quarter of 2006, thanks to strong growth in revenue from its defibrillation products and cardiac monitoring line. For the year, revenue is expected to exceed $181 million, representing year-over-year growth of approximately 17 percent compared to 2006, according to preliminary revenue results for the fourth quarter ended December 31, 2007. “Defibrillation revenue continues to benefit from solid demand for AEDs both domestically and internationally and we realized meaningful revenue during the fourth quarter from sales of our recently-introduced crash cart defibrillator, consistent with our earlier expectations," said John Hinson, president and chief executive officer. Fourth quarter 2007 revenue estimates are preliminary. The Company expects to announce its full financial results for the fourth quarter 2007 in late February 2008. For more information:

Related Content

Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Predictive Models May Help Determine Which Patients Benefit From ICDs
News | Implantable Cardioverter Defibrillator (ICD)| July 06, 2017
Two predictive models may help cardiologists decide which patients would most benefit from an implantable cardioverter...
Medtronic Reactive ATP Therapy Slows Progression of Atrial Fibrillation in Real-World Population
News | Atrial Fibrillation| July 03, 2017
Medtronic recently announced that its Reactive ATP therapy slows the progression of atrial fibrillation (AF) in...
Sponsored Content | Videos | Cardiovascular Ultrasound| June 29, 2017
Leyla Elif Sade, M.D., MESC, professor of cardiology at Başkent University, Ankara, Turkey, discusses use of echo for
Biosense webster multielectrode balloon RF ablation catheter

The Biosense Webster multi-electrode balloon RF ablation catheter. Each electrode can have varied power settings to avoid damage to underlying tissues like the esophagus. 

Feature | EP Lab| June 22, 2017 | Dave Fornell
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve...
Pacemakers and Other Cardiac Devices Can Help Solve Forensic Cases
News | Pacemakers| June 20, 2017
Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented at the European...
Sponsored Content | Videos | Implantable Cardioverter Defibrillator (ICD)| June 01, 2017
Lucas Boersma, M.D., Ph.D., FESC, St.
Sponsored Content | Videos | Leads Implantable Devices| May 25, 2017
Bruce Wilkoff, M.D., director of cardiac pacing and tachyarrhythmia devices at Cleveland Clinic, discusses advancemen
Overlay Init